Summary
Five Prime Therapeutics , Inc.
Founded in 2006
Description
Five Prime Therapeutics is a biotechnology company focused on the discovery and development of first-in-class protein and antibody drugs for oncology and immunology.
Strengths
- Five Prime Therapeutics , Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Since Five Prime Therapeutics , Inc. was founded, the company has grown faster than the industry average
Weaknesses
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
Five Prime Therapeutics , Inc.'s annual revenue
$32898000
Based on Kona Equity data
-
Revenue per employee
$168708
-
Annual revenue growth since founding
$1827666
-
Revenue growth rate from first known quarter to current
26.2%
Employee Count
195 employees
-
Employee growth rate from first known quarter to current
-2.8%
Executives
Tom Civik
President & Chief Executive Officer
t**@fiveprime.comDat Mac
Senior Clinical Trials Manager (Consultant)
d**@fiveprime.comEmily Chao
Director, Quality Assurance
e**@fiveprime.comVeronica Miller
Senior Buyer
v**@fiveprime.comKevin Hestir
Executive Director, Bioinformatics
k**@fiveprime.comMarc Lopez
Director, Clinical Operations
m**@fiveprime.comAnthony Tzeng
Senior Clinical Trial Associate
a**@fiveprime.comCarol Huang
Sciences Vice President, Manufacturing
c**@fiveprime.comBrian Druce
Vice President, Quality
b**@fiveprime.comShirley Shi
Senior Research Specialist
s**@fiveprime.comSonali Patil
Scientist
s**@fiveprime.comBrian Norris
Immuno-Oncology Research Scientist I
b**@fiveprime.comAaron Linen
Shipping Receiving Manager
a**@fiveprime.comCharles Yates
Pharmacy Support
c**@fiveprime.comAndrea Danforth
Interim Head of Human Resources
a**@fiveprime.comDan Mcdonough
Research, Hts Assay Development Associate
d**@fiveprime.comKristi Burger
Buyer II
k**@fiveprime.comPeter Gompper
Program Manager, Clinical
p**@fiveprime.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Web Analysis
-
Rank
5.4 M
-
Page views per visitor
1.0
-
Daily time
-
Location
Unlock unlimited leads
Similar Companies
Calithera Biosciences Inc
calithera.com- Founded in 2010
- Location: South San Francisco, CA
- Annual Revenue: $9.8M
- Employees: 63
- Calithera is developing first-in-class small molecule drugs directed against tumor metabolism and tumor immunology targets to treat cancer.
Sanford Consortium for Regenerative Medicine
sanfordconsortium.com- Location: La Jolla, CA
- Annual Revenue: $4.4M
- Employees: 5
- The Sanford Consortium for Regenerative Medicine is a non-profit organization dedicated to advancing stem cell research and regenerative medicine. Our mission is to accelerate the development of new therapies and cures for a wide range of diseases and ...
Alexo Therapeutics
alxoncology.com- Founded in 2015
- Location: Burlingame, CA
- Annual Revenue: $9.1M
- Employees: 44
- ALX Oncology is a clinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
StemVax Therapeutics
stemvax.com- Founded in 2014
- Location: Los Angeles, CA
- Annual Revenue: $781.0K
- Employees: 4
- StemVax is a biopharmaceutical company developing novel immunotherapies to treat brain tumor patients. StemVax is an Innovest Global Partner, IVST.
Inscent Inc
inscent.com- Location: Irvine, CA
- Annual Revenue: $5.4M
- Employees: 19
- Inscent, Inc. is a technology development, gene discovery, and functional genomics company that identified novel molecules to control insect pests. Key areas of interest include the prevention of disease transmission to humans and the development of en...
geneandcell.com
geneandcell.com- Location: Vallejo, CA
- Annual Revenue: $5.2M
- Employees: 15
- Gene And Cell Technologies is a vertically integrated regenerative medicine company. We race to develop cures for all diseases using true cell replacement medi
Key Information
- Name: Five Prime Therapeutics , Inc.
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 2834; 87
- NAICS: 32541; 5417
See similar companies
-
By City South San Francisco Small Biotechnology Company in South San Francisco Mid-size Biotechnology Company in South San Francisco Pharmaceuticals in South San Francisco Small Pharmaceuticals in South San Francisco Mid-size Pharmaceuticals in South San Francisco
-
By State CA Small companies in CA Pharmaceuticals in CA Small Pharmaceuticals in CA Mid-size Pharmaceuticals in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 3 Founded in 2006 SIC: 2834 SIC: 87 NAICS: 32541 NAICS: 5417 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Five Prime Therapeutics , Inc.'s headquarters are located at 111 OYSTER POINT Blvd. South San Francisco, CA 94080.
Five Prime Therapeutics , Inc.'s official website is fiveprime.com
Five Prime Therapeutics , Inc.'s annual revenue is $32.9 M.
Five Prime Therapeutics , Inc.'s SIC: 2834; 87
Five Prime Therapeutics , Inc.'s NAICS: 32541; 5417.
Five Prime Therapeutics , Inc. has 195 employees
Five Prime Therapeutics , Inc. is in the industry of Pharmaceuticals.
